News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ferraresso Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2023 |
4
| Ferraresso Michael (Chief Commercial Officer) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 16,345 shares
@ $15, valued at
$245.2k
Disposed/sold 20,000 options to buy
@ $28.3, valued at
$566k
Disposed/sold 3,749 options to buy
@ $30.8, valued at
$115.5k
Disposed/sold 35,064 options to buy
@ $6.2, valued at
$217.4k
Disposed/sold 42,499 options to buy
@ $5.6, valued at
$238k
Disposed/sold 100,000 options to buy
@ $9.12, valued at
$912k
Disposed/sold 220,000 options to buy
@ $3.67, valued at
$807.4k
|
|
| 05/13/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 02/17/2022 |
4
| Ferraresso Michael (Chief Commercial Officer) has filed a Form 4 on AVEO PHARMACEUTICALS, INC.|
Txns:
| Granted 220,000 options to buy
@ $3.67, valued at
$807.4k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|